Botox Market Overview

The report is titled ‘Botox Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the botox market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. The botox market is expected to grow with significant rate in the near future.

The global botox market in 2020 is estimated for more than US$ 4.4 Bn and expected to reach a value of US$ 7.8 Bn by 2028 with a significant CAGR of 7.5%.

Botox Market Definition

Over the past several years, a number of new soft tissue augmentation products, commonly called derma fillers have emerged into the global market for use in the treatment of the signs of aging. Cosmetic dermal filler procedures are increasingly becoming popular due to the advent of botulinum toxin, type A, for the treatment of expression lines, and signs of aging on the face. A recent survey conducted by the American Society for Aesthetic Plastic Surgery (ASAPS) showed that injection of botulinum toxin, type A, is the most common non-surgical procedure performed in the U.S. Botox is gaining importance in soft tissue fillers over the past several years.

Botox Market Dynamics

Aging face eventually loses subcutaneous volume over time, which results in an increase in lines and wrinkles of the skin. Botox plays an important function in correcting changes associated with aging and wrinkles primarily in the lower one-half of the face.

The growing number of cosmetic surgery procedures is the primary factor driving the growth of the global Botox market. According to the American Society for Aesthetic Plastic Surgery (ASAPS), there has been a 48% increase in the number of dermal filler procedures performed in the U.S. during 2012 and 2015.

In aesthetic medicine, the botulinum toxin is predominately used type A so far. Although some trials have been published for use of type-B botulinum toxin, and successful launch of this is expected to drive the growth of the market. Side effects and risks associated with the use of botulinum toxin are the important factors limiting the widespread use of these products.

The global botox market is expected to increase at a significant CAGR over the forecast period owing to the growing number of FDA approvals and penetration of cosmetic and aesthetic procedures in emerging markets.

Botox Market Key Players

The market for botox is dominated by a few global players accounting for a majority of the global market share. Some of the key players identified in the botox market are Allergan Inc., Galderma SA, Merz Pharma GmbH & Co. KGaA, Eisai Ltd., and others.

Botox Market Segmentation

The global botox market is segmented on the basis of product type, distribution channels, and region. On the basis of product type, the global botox market is segmented into Vistabel/Vistabex, Xeomin, NeuroBloc, and Dysport. On the basis of the distribution channels, the global botox market can be segmented into hospital pharmacies, retail pharmacies, dermal clinics, and cosmetology & beauty clinics.

By Product type

•    Vistabel/Vistabex

•    Xeomin

•    NeuroBloc

•    Dysport

By End-User

•    Hospital Pharmacies

•    Retail Pharmacies

•    Dermal Clinics

•    Cosmetology & Beauty Clinics

Botox Market Regional Overview and Analysis

On the basis of region, the global botox market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America botox market will continue to dominate the global market throughout the forecast period due to growing cosmetic industry. Europe is the second-largest market for botox with Germany, U.K, and France being the most prominent markets.

MMC Overview on Botox Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.

A research report on the Botox market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth include (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Botox

•    Advantage of Botox

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at a regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make an informed decision.

A mix of the top-down and bottom-up approach is followed to arrive at and validate our market value estimations. For a product segment wherein one/two manufacturer(s) dominates the market, its product sales, previous growth rates, and market expansion plans are considered to generate market share in the global market.

1.    Global Botox Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Botox Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Botox Market Snapshot

2.4.    Global Botox Market Size and Forecast, 2019–2027

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)

2.5.    Global Botox Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Botox Market, By Product Type

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Product Type

3.1.2.    BPS Analysis, By Product Type

3.2.    Market Revenue (US$Mn) Forecast, By Product Type

3.2.1.    Vistabel/Vistabex

3.2.2.    Xeomin

3.2.3.    NeuroBloc

3.2.4.    Dysport

3.3.    Global Botox Market Attractiveness Index, By Product Type

4.    Global Botox Market, By Distribution Channel

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Distribution Channel

4.1.2.    BPS Analysis, By Distribution Channel

4.2.    Market Revenue (US$Mn) Forecast, By Distribution Channel

4.2.1.    Hospital Pharmacies

4.2.2.    Retail Pharmacies

4.2.3.    Dermal Clinics

4.2.4.    Cosmetology & Beauty Clinics

4.3.    Global Botox Market Attractiveness Index, By Distribution Channel

5.    Global Botox Market, By Region

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Region

5.1.2.    BPS Analysis, By Region

5.2.    Market Revenue (US$Mn) Forecast, By Region

5.2.1.    North America

5.2.2.    Latin America

5.2.3.    Europe

5.2.4.    Asia Pacific

5.2.5.    Middle East and Africa

5.3.    Global Botox Market Attractiveness Index, By Region

6.    North America Botox Market Analysis and Forecast, 2019–2027

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Country

6.1.2.    BPS Analysis, By Country

6.2.    Market Revenue (US$Mn) Forecast, By Country

6.2.1.    U.S. Botox Market

6.2.2.    Canada Botox Market

6.3.    North America Botox Market, By Product Type

6.3.1.    Vistabel/Vistabex

6.3.2.    Xeomin

6.3.3.    NeuroBloc

6.3.4.    Dysport

6.4.    North America Botox Market, By Distribution Channel

6.4.1.    Hospital Pharmacies

6.4.2.    Retail Pharmacies

6.4.3.    Dermal Clinics

6.4.4.    Cosmetology & Beauty Clinics

6.5.    North America Botox Market Attractiveness Index

6.5.1.    By Country

6.5.2.    By Product Type

6.5.3.    By Distribution Channel

7.    Latin America Botox Market Analysis and Forecast, 2019–2027

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market (US$Mn) Forecast, By Country

7.2.1.    Brazil Botox Market

7.2.2.    Mexico Botox Market

7.2.3.    Argentina Botox Market

7.2.4.    Rest of Latin America Botox Market

7.3.    Latin America Botox Market, By Product Type

7.3.1.    Vistabel/Vistabex

7.3.2.    Xeomin

7.3.3.    NeuroBloc

7.3.4.    Dysport

7.4.    Latin America Botox Market, By Distribution Channel

7.4.1.    Hospital Pharmacies

7.4.2.    Retail Pharmacies

7.4.3.    Dermal Clinics

7.4.4.    Cosmetology & Beauty Clinics

7.5.    Latin America Botox Market Attractiveness Index

7.5.1.    By Country

7.5.2.    By Product Type

7.5.3.    By Distribution Channel

8.    Europe Botox Market Analysis and Forecast, 2019–2027

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    U.K. Botox Market

8.2.2.    Germany Botox Market

8.2.3.    Italy Botox Market

8.2.4.    France Botox Market

8.2.5.    Spain Botox Market

8.2.6.    Russia Botox Market

8.2.7.    Poland Botox Market

8.2.8.    BENELUX Botox Market

8.2.9.    NORDIC Botox Market

8.2.10.    Rest of Europe Botox Market

8.3.    Europe Botox Market, By Product Type

8.3.1.    Vistabel/Vistabex

8.3.2.    Xeomin

8.3.3.    NeuroBloc

8.3.4.    Dysport

8.4.    Europe Botox Market, By Distribution Channel

8.4.1.    Hospital Pharmacies

8.4.2.    Retail Pharmacies

8.4.3.    Dermal Clinics

8.4.4.    Cosmetology & Beauty Clinics

8.5.    Europe Botox Market Attractiveness Index

8.5.1.    By Country

8.5.2.    By Product Type

8.5.3.    By Distribution Channel

9.    Asia Pacific Botox Market Analysis and Forecast, 2019–2027

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    China Botox Market

9.2.2.    India Botox Market

9.2.3.    Japan Botox Market

9.2.4.    Australia and New Zealand Botox Market

9.2.5.    South Korea Botox Market

9.2.6.    ASEAN Botox Market

9.2.7.    Rest of Asia Pacific Botox Market

9.3.    Asia Pacific Botox Market, By Product Type

9.3.1.    Vistabel/Vistabex

9.3.2.    Xeomin

9.3.3.    NeuroBloc

9.3.4.    Dysport

9.4.    Asia Pacific Botox Market, By Distribution Channel

9.4.1.    Hospital Pharmacies

9.4.2.    Retail Pharmacies

9.4.3.    Dermal Clinics

9.4.4.    Cosmetology & Beauty Clinics

9.5.    Asia Pacific Botox Market Attractiveness Index

9.5.1.    By Country

9.5.2.    By Product Type

9.5.3.    By Distribution Channel

10.    Middle East Botox Market, By Region

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    GCC Countries Botox Market

10.2.2.    Israel Botox Market

10.2.3.    Oman Botox Market

10.2.4.    Rest of Middle East Botox Market

10.3.    Middle East Botox Market, By Product Type

10.3.1.    Vistabel/Vistabex

10.3.2.    Xeomin

10.3.3.    NeuroBloc

10.3.4.    Dysport

10.4.    Middle East Botox Market, By Distribution Channel

10.4.1.    Hospital Pharmacies

10.4.2.    Retail Pharmacies

10.4.3.    Dermal Clinics

10.4.4.    Cosmetology & Beauty Clinics

10.5.    Middle East Botox Market Attractiveness Index

10.5.1.    By Country

10.5.2.    By Product Type

10.5.3.    By Distribution Channel

11.    Africa Botox Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    South Africa Botox Market

11.2.2.    Egypt Botox Market

11.2.3.    North Africa Botox Market

11.2.4.    Rest of Africa Botox Market

11.3.    Africa Botox Market, By Product Type

11.3.1.    Vistabel/Vistabex

11.3.2.    Xeomin

11.3.3.    NeuroBloc

11.3.4.    Dysport

11.4.    Africa Botox Market, By Distribution Channel

11.4.1.    Hospital Pharmacies

11.4.2.    Retail Pharmacies

11.4.3.    Dermal Clinics

11.4.4.    Cosmetology & Beauty Clinics

11.5.    Africa Botox Market Attractiveness Index

11.5.1.    By Country

11.5.2.    By Product Type

11.5.3.    By Distribution Channel

12.    Recommendation

12.1.    Market Strategy

13.    Competitive Landscape

13.1.    Competition Dashboard

13.2.    List and Company Overview of Global Key Players

13.3.    Company Profiles

13.3.1.    Allergan Inc.

13.3.1.1.    Company Overview

13.3.1.2.    Financial Overview

13.3.1.3.    Product Portfolio

13.3.1.4.    Key Developments

13.3.1.5.    Business Strategies

13.3.2.    Galderma SA

13.3.3.    Merz Pharma GmbH & Co. KGaA

13.3.4.    Eisai Ltd.

13.3.5.    US WorldMeds

13.3.6.    Medytox

13.3.7.    LIBP

14.    Acronyms